AI is going to reinvent drug discovery. Probably. Every week we check which promises actually panned out.
Aug 28, 2026
•
3 min read
Weekly Roundup
Instead, better models may be making Big Pharma’s decades of failed experiments more valuable.
Just not the jobs people expect.
Aug 21, 2026
Formation Bio’s unusual AI strategy starts with an idea about where drug discovery is heading.
Aug 14, 2026
Inside Pathos AI’s plan to search for clinical assets, acquire them and apply a repeatable development system.
Aug 7, 2026
